Literature DB >> 8677777

Sexual risk behavior and history of sexually transmitted diseases in relation to casual travel sex during different types of journeys.

M Arvidson1, D Hellberg, P A Mårdh.   

Abstract

OBJECTIVES: The study investigated if women with experience of casual travel sex, with a previously unknown man abroad, on different types of journeys (charter, vagabond, business and education trips), differ with regard to sexual risk behavior and history of sexually transmitted diseases (STDs). STUDY
DESIGN: The study population consisted of 996 women. Of these, 27.7% admitted that they had had casual sex during journeys. The remaining women were used as a comparison group. History of STDs and sexual risk behaviors were investigated.
RESULTS: The frequency of women who had more than ten lifetime sexual partners were greatly increased in all groups, as compared to the controls. A history of gonorrhea was most frequent among the charter travellers. A history of genital chlamydial infection was most common among the vagabond travellers. The lowest frequencies of a history of STDs was observed in women engaging in casual sex on 'business' journeys and they had significantly less often a history of STDs as compared to the charter travellers. A high frequency of STDs were seen in women who had experience of casual sex on different types of journeys.
CONCLUSION: Women on business trips, although they had a similar sexual risk behaviour as the other groups of travellers, had less often a history of STDs.

Entities:  

Mesh:

Year:  1996        PMID: 8677777     DOI: 10.3109/00016349609033360

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Sexually Transmitted Diseases in Travelers.

Authors:  Noreen A Hynes
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.663

2.  Travel abroad increases sexual health risk-taking among Swedish youth: a population-based study using a case-crossover strategy.

Authors:  Mats Sundbeck; Anette Agardh; Per-Olof Östergren
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.